Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11261188
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
granted -
US 11261151
Methods for making and using endoxifen
granted -
US 11261152
Inhibitors of the N-terminal domain of the androgen receptor
granted -
US 11261164
Small molecule agonists of neurotensin receptor 1
granted -
US 11260089
Products of manufacture comprising bacteriophages
granted -
US 11260073
Compounds and methods for modulating C90RF72
granted -
US 11260070
Methods of treating feline coronavirus infections
granted -
US 11260120
Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
granted -
US 11260092
Fungal immunogens and related materials and methods
granted -
US 11260050
Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological
granted -
US 11261437
Procoagulant compounds
granted -
US 11254912
Methods and compositions for treating cancer
granted -
US 11254746
Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof
granted -
US 11254739
Anti-human migration stimulating factor (MSF) and uses thereof
granted -
US 11254735
Prevention of tissue ischemia and related methods
granted -
US 11254913
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11254725
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 11254713
Method to enhance immunogenicity of live typhoid vaccines and carriers
granted -
US 11254683
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 11254669
Fused imidazo-piperidine JAK inhibitors
granted -
US 11254667
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors
granted -
US 11254666
Compound as GLS1 inhibitor
granted -
US 11254686
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
granted -
US 11254662
2′-halogenated-4′-thio-2′-deoxy-5-azacytidine analogs and use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.